These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 37109585)

  • 1. Pathophysiological Effects of Contemporary Lifestyle on Evolutionary-Conserved Survival Mechanisms in Polycystic Ovary Syndrome.
    Parker J
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental origins and transgenerational inheritance of polycystic ovary syndrome.
    Parker J; O'Brien C; Gersh FL
    Aust N Z J Obstet Gynaecol; 2021 Dec; 61(6):922-926. PubMed ID: 34403138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment.
    Parker J; O'Brien C; Hawrelak J; Gersh FL
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome and environmental toxins.
    Rutkowska AZ; Diamanti-Kandarakis E
    Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics.
    Singh S; Pal N; Shubham S; Sarma DK; Verma V; Marotta F; Kumar M
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic Ovary Syndrome: A Contemporary Clinical Approach.
    Bjekić-Macut J; Vukašin T; Velija-Ašimi Z; Bureković A; Zdravković M; Andrić Z; Branković M; Crevar-Marinović S; Madić T; Stanojlović O; Milutinović DV; Livadas S; Mastorakos G
    Curr Pharm Des; 2021; 27(36):3812-3820. PubMed ID: 33463457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of a pulse-based diet on infertility measures and metabolic syndrome risk: protocol of a randomized clinical trial in women with polycystic ovary syndrome.
    McBreairty LE; Chilibeck PD; Chizen DR; Pierson RA; Tumback L; Sherar LB; Zello GA
    BMC Nutr; 2017; 3():23. PubMed ID: 32153805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.
    Wang J; Wu D; Guo H; Li M
    Life Sci; 2019 Nov; 236():116940. PubMed ID: 31604107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder.
    Charifson MA; Trumble BC
    Evol Med Public Health; 2019; 2019(1):50-63. PubMed ID: 31367382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
    Siddiqui S; Mateen S; Ahmad R; Moin S
    J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay between androgens and the immune response in polycystic ovary syndrome.
    Shabbir S; Khurram E; Moorthi VS; Eissa YTH; Kamal MA; Butler AE
    J Transl Med; 2023 Apr; 21(1):259. PubMed ID: 37062827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?
    Morgante G; Troìa L; De Leo V
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105770. PubMed ID: 33065278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome.
    Macut D; Bjekić-Macut J; Livadas S; Stanojlović O; Hrnčić D; Rašić-Marković A; Milutinović DV; Mladenović V; Andrić Z
    Curr Pharm Des; 2018; 24(38):4593-4597. PubMed ID: 30652641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy.
    Patel S
    J Steroid Biochem Mol Biol; 2018 Sep; 182():27-36. PubMed ID: 29678491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.
    Teede H; Deeks A; Moran L
    BMC Med; 2010 Jun; 8():41. PubMed ID: 20591140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.